Protocols for isolation and characterization of nanoparticle biomolecular corona complexes

Autor: Mahmoud G. Soliman, Alberto Martinez-Serra, Marko Dobricic, Duong N. Trinh, Jack Cheeseman, Daniel I. R. Spencer, Marco P. Monopoli

Publikováno v: Frontiers in Toxicology, Vol 6 (2024)

Engineered nanoparticles (NPs) pose a broad spectrum of interesting properties that make them useful for many applications. However, continuous exposure to NPs requires the need to deeply understand the outcomes when these NPs interact with different

Externí odkaz: https://doaj.org/article/fa84352f2ef74286a1634c9aa809028c

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Evaluating modelled tropospheric columns of CH4, CO, and O3 in the Arctic using ground-based Fourier transform infrared (FTIR) measurements

Autor: V. A. Flood, K. Strong, C. H. Whaley, K. A. Walker, T. Blumenstock, J. W. Hannigan, J. Mellqvist, J. Notholt, M. Palm, A. N. Röhling, S. Arnold, S. Beagley, R.-Y. Chien, J. Christensen, M. Deushi, S. Dobricic, X. Dong, J. S. Fu, M. Gauss, W. Gong, J. Langner, K. S. Law, L. Marelle, T. Onishi, N. Oshima, D. A. Plummer, L. Pozzoli, J.-C. Raut, M. A. Thomas, S. Tsyro, S. Turnock

Publikováno v: Atmospheric Chemistry and Physics, Vol 24, Pp 1079-1118 (2024)

This study evaluates tropospheric columns of methane, carbon monoxide, and ozone in the Arctic simulated by 11 models. The Arctic is warming at nearly 4 times the global average rate, and with changing emissions in and near the region, it is importan

Externí odkaz: https://doaj.org/article/964293e1342d47d9a56139b0ebeb16a7

Estimation of passive gastrointestinal absorption of new dual DNA gyrase and topoisomerase IV inhibitors using PAMPA and biopartitioning micellar chromatography and quantitative structure-retention relationship analysis

Autor: Dobričić, Vladimir, Marodi, Marko, Marković, Bojan, Tomašič, Tihomir, Durcik, Martina, Zidar, Nace, Mašič, Lucija Peterlin, Ilaš, Janez, Kikelj, Danijel, Čudina, Olivera

Publikováno v: In Journal of Chromatography B 1 June 2024 1240

Blood-based multivariate methylation risk score for cognitive impairment and dementia.

Autor: Koetsier J; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNs), Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands.; Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands., Cavill R; Department of Advanced Computing Sciences (DACS), Faculty of Science and Engineering (FSE), Maastricht University, Maastricht, The Netherlands., Reijnders R; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNs), Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands., Harvey J; Medical School, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK., Homann J; Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany., Kouhsar M; Medical School, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK., Deckers K; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNs), Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands., Köhler S; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNs), Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands., Eijssen LMT; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNs), Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands.; Department of Bioinformatics - BiGCaT, Research Institute of Nutrition and Translational Research in Metabolism (NUTRIM), Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands., van den Hove DLA; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNs), Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands.; Department of Psychiatry, Psychosomatics and Psychotherapy, University of Wuerzburg, Dr. Manuel Nagel, Würzburg, Germany., Demuth I; Department of Endocrinology and Metabolic Diseases (including Division of Lipid Metabolism), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; BCRT - Berlin Institute of Health Center for Regenerative Therapies, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany., Düzel S; Center for Lifespan Psychology, Max Planck Institute for Human Development, Berlin, Germany., Smith RG; Medical School, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK., Smith AR; Medical School, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK., Burrage J; Medical School, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK., Walker EM; Medical School, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK., Shireby G; Medical School, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK., Hannon E; Medical School, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK., Dempster E; Medical School, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK., Frayling T; Medical School, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK., Mill J; Medical School, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK., Dobricic V; Lübeck Interdisciplinary Platform for Genome Analytics (LIGA), University of Lübeck, Lübeck, Germany., Johannsen P; Danish Dementia Research Centre, Rigshospitalet, Copenhagen, Denmark., Wittig M; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany., Franke A; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany., Vandenberghe R; Laboratory for Cognitive Neurology, KU Leuven, Leuven, Belgium., Schaeverbeke J; Laboratory for Cognitive Neurology, KU Leuven, Leuven, Belgium., Freund-Levi Y; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.; School of Medical Sciences, Örebro University, Örebro, Sweden.; Department of Geriatrics, Södertälje Hospital, Södertälje, Sweden., Frölich L; Department of Geriatric Psychiatry, Central Institute of Mental Health; Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany., Scheltens P; Department of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands., Teunissen CE; Neurochemistry Laboratory, Department of Laboratory Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands., Frisoni G; Memory Center, Geneva University and University Hospitals; on behalf of the AMYPAD Consortium, Genève, Switzerland., Blin O; Aix-Marseille University-CNRS, Marseille, France., Richardson JC; Neuroscience Therapeutic Area, GlaxoSmithKline R&D, Stevenage, Hertfordshire, UK., Bordet R; Université de Lille, Lille Cedex, France., Engelborghs S; Department of Biomedical Sciences, University of Antwerp, Antwerpen, Belgium.; Neuroprotection & Neuromodulation (NEUR) Research Group, Center for Neurosciences (C4N), Vrije Universiteit Brussel (VUB), Jette, Brussels, Belgium., de Roeck E; Department of Biomedical Sciences, University of Antwerp, Antwerpen, Belgium., Martinez-Lage P; Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, Gipuzkoa, Spain., Tainta M; Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, Gipuzkoa, Spain., Lleó A; Neurology Department, Centro de Investigación en Red en enfermedades neurodegenerativas (CIBERNED), Hospital Sant Pau, Sant Antoni Maria Claret, Barcelona, Spain., Sala I; Neurology Department, Centro de Investigación en Red en enfermedades neurodegenerativas (CIBERNED), Hospital Sant Pau, Sant Antoni Maria Claret, Barcelona, Spain., Popp J; University Hospital of Psychiatry Zürich, University of Zürich, Zürich, Switzerland., Peyratout G; Department of Psychiatry, University Hospital of Lausanne (CHUV), Lausanne, Switzerland., Verhey F; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNs), Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands., Tsolaki M; 1st Department of Neurology, School of Medicine, `Laboratory of Neurodegenerative Diseases, Center for Interdisciplinary Research and Innovation, Aristotle University of Thessaloniki, and Alzheimer Hellas, Macedonia, Balkan Center, Thessaloniki, Greece., Andreasson U; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Göteborg, Sweden., Blennow K; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Göteborg, Sweden.; Clinical Neurochemistry Lab, Sahlgrenska University Hospital, Göteborg, Sweden.; Paris Brain Institute, ICM, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France.; Neurodegenerative Disorder Research Center, Division of Life Sciences and Medicine, and Department of Neurology, Institute on Aging and Brain Disorders, University of Science and Technology of China and First Affiliated Hospital of USTC, Hefei, P.R. China., Zetterberg H; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Göteborg, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at UCL, Maple House, London, UK.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Shatin, N.T., Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA., Streffer J; AC Immune SA, formerly Janssen R&D, LLC. Beerse, Belgium at the time of study conduct, Lausanne, Switzerland., Vos SJB; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNs), Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands., Lovestone S; University of Oxford, Oxford, United Kingdom; Currently at Johnson & Johnson Innovative Medicines, Beerse, Belgium., Visser PJ; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNs), Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands.; Department of Geriatrics, Södertälje Hospital, Södertälje, Sweden., Lill CM; Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.; Ageing Epidemiology Research Unit, School of Public Health, Imperial College, South Kensington Campus, London, UK., Bertram L; Lübeck Interdisciplinary Platform for Genome Analytics (LIGA), University of Lübeck, Lübeck, Germany., Lunnon K; Medical School, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK., Pishva E; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNs), Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, Maastricht, The Netherlands.; Medical School, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.

Publikováno v: Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2024 Oct; Vol. 20 (10), pp. 6682-6698. Date of Electronic Publication: 2024 Aug 28.